Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression With Focus on Breast Cancer Therapeutic Outcomes [0.03%]
肿瘤内微生物群：聚焦于乳腺癌治疗效果解开其致癌对癌症进展的影响
Chun-Ming Chang,Ho Yin Pekkle Lam
Chun-Ming Chang
The gut microbiota has been implicated in many cancers through the secretion of blood-traveling metabolites or activation of oncogenic signaling. Currently, specific microbial signatures have been detected in the human breast, which are dif...
Clinical Impact of Pelvic Sentinel Lymph Node Biopsy for Vulvar Squamous Cell Carcinoma [0.03%]
用于外阴鳞状细胞癌的盆腔SENTINEL淋巴结活检的临床影响
Bernd Morgenstern,Fabinshy Thangarajah,Matthias Schmidt et al.
Bernd Morgenstern et al.
Background/aim: This study investigated the clinical impact of resection of pelvic sentinel lymph nodes (PSLNs) in squamous cell vulvar cancer (SCVC). Pat...
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer [0.03%]
小细胞肺癌患者阿特朱单抗联合化疗临床实践体会
Satoshi Ano,Norihiro Kikuchi,Shinichiro Okauchi et al.
Satoshi Ano et al.
Background/aim: Atezolizumab, an anti-PD-L1 antibody, has been increasingly administered in combination with chemotherapy to patients with small cell lung cancer (SCLC). This study aimed to determine how patients with ext...
Anticancer Activity of HER2-targeting CPP-PTEN-THP Chimeric Proteins [0.03%]
HER2靶向CPP-PTEN-THP嵌合蛋白的抗肿瘤活性
Elizeth Pioquinto-Avila,Aldo O González-Cruz,Jorge Solís-Estrada et al.
Elizeth Pioquinto-Avila et al.
Background/aim: Protein phosphatase and tensin homolog (PTEN) is a tumor suppressor protein with potential to be a new biotechnological drug for PTEN-deficient cancer treatment. This study aimed to develop PTEN-based chim...
Adverse Event Profile of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Combination Therapy Based on JADER [0.03%]
基于JADER的阿特珠单抗、贝伐珠单抗、卡铂和紫杉醇联合疗法不良事件特征分析
Kiri Endo,Hiroyuki Tanaka,Hajime Matsuo et al.
Kiri Endo et al.
Background/aim: There have been advances in the development of immune checkpoint inhibitors for monotherapy and combination therapy with other anticancer agents in recent years. The combination of bevacizumab, carboplatin...
Short-term Outcomes of Laparoscopic Versus Open Liver Resection in the Elderly: A Propensity Score-matched Analysis [0.03%]
老年患者腹腔镜与开腹肝切除短期疗效的倾向性匹配分析
Yosuke Igarashi,Koichiro Haruki,Kenei Furukawa et al.
Yosuke Igarashi et al.
Background/aim: With the aging of the population, there is a rising proportion of elderly patients undergoing liver resection. However, the safety and efficacy of laparoscopic liver resection (LLR) in the elderly have not...
Comparative Study
Anticancer research. 2024 Jun;44(6):2731-2736. DOI:10.21873/anticanres.17081 2024
Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane Antigen [0.03%]
靶向前列腺特异性膜抗原的抗体和Fab片段用于治疗前列腺癌光免疫疗法
Sarah Waibel,Nele Graf,Jonas Storz et al.
Sarah Waibel et al.
Background/aim: The standard treatment for localized prostate cancer involves surgical removal of the prostate with curative intent. However, when tumor cells persist in the operation site, there is high risk of local rec...
Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic Success [0.03%]
治疗HER2阳性cT4cN+乳腺癌的新辅助治疗案例报告：疗效成功分析
Marco Gunnellini,Antonio Tornincasa,Michele Montedoro et al.
Marco Gunnellini et al.
Background: HER2 positive disease accounts for 15-20% of early breast cancer. Achieving a pathological complete response after neoadjuvant chemotherapy (NACT) improves prognosis and decreases risk of recurrence. ...
A Comparative Analysis of ARX and ANFIS Models for Tumor Growth Prediction Under Single and Multi-agent Chemotherapy [0.03%]
基于单一和多药化疗的肿瘤生长预测的ARX与ANFIS模型比较分析
Sotirios G Liliopoulos,George S Stavrakakis,Konstantinos S Dimas
Sotirios G Liliopoulos
Background/aim: Despite the advances in oncology and cancer treatment over the past decades, cancer remains one of the deadliest diseases. This study focuses on further understanding the complex nature of cancer by using ...
Comparative Study
Anticancer research. 2024 Jun;44(6):2425-2436. DOI:10.21873/anticanres.17049 2024
Harnessing Micronutrient Power: Vitamins, Antioxidants and Probiotics in Breast Cancer Prevention [0.03%]
微营养素的防癌作用：维生素、抗氧化剂和益生菌在乳腺癌预防中的应用
Kinan Mokbel,Kefah Mokbel
Kinan Mokbel
Breast cancer remains a global health challenge, prompting a search for preventive strategies beyond conventional approaches. This review explores the potential of specific micronutrients, including antioxidants, vitamins, and probiotics, i...